Prognostic value of expanded liver transplantation criteria—the 5‐5‐500 rule—in patients with hepatic resection for intermediate‐stage hepatocellular carcinoma
Authors:
- 23 June 2020
- journal article
- research article
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 27 (10) , 682-689
Abstract
Background: This study aimed to evaluate the prognostic impact of the 5‐5‐500 rule in patients after hepatic resection for the intermediate stage of hepatocellular carcinoma (HCC; The Barcelona Clinic Liver Cancer classification [BCLC] B).Methods: 177 patients had hepatic resection for BCLC‐B HCC. The 5‐5‐500 rule was defined by tumor size ≤5 cm in diameter, tumor number ≤5, and α‐fetoprotein ≤500 ng/mL.Results: The 3‐, 5‐, and 7‐year recurrence‐free survival rates were 22%, 14%, and 11% in patients within the 5‐5‐500 rule, and 16%, 10%, and 10% in patients beyond the 5‐5‐500 rule, respectively (P = .015). The 3‐, 5‐, and 7‐year overall survival rates were 72%, 47%, and 34% in patients within the 5‐5‐500 rule, and 52%, 31%, and 25% in patients beyond the 5‐5‐500 rule, respectively (P = .035). Being beyond the 5‐5‐500 rule and liver cirrhosis were independent prognostic factors for recurrence‐free survival. For overall survival, being beyond the 5‐5‐500 rule, age ≥65 years, Child–Pugh class B, and anti‐hepatitis C antibody positive were identified as independent prognostic factors.Conclusions: The 5‐5‐500 rule could predict prognosis in BCLC‐B patients with hepatic resection. Hepatic resection might provide survival benefit for selected patients with BCLC‐B HCC within the 5‐5‐500 rule.Keywords
This publication has 27 references indexed in Scilit:
- Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial designJournal of Hepatology, 2012
- Superselective transarterial chemoembolization for hepatocellular carcinoma. Validation of treatment algorithm proposed by Japanese guidelinesJournal of Hepatology, 2012
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated VersionDigestive Diseases, 2011
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Living Donor Liver Transplantation for Adult Patients With Hepatocellular CarcinomaAnnals of Surgery, 2004
- Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: An outcome-oriented decision analysisHepatology, 2000
- Surgery for small liver cancersSeminars in Surgical Oncology, 1993
- The general rules for the clinical and pathological study of primary liver cancerSurgery Today, 1989
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981